Research trends in essential thrombocythemia from 2001 to 2024: a bibliometric analysis
Bibliometric analysis demonstrates significant advances in ET research, particularly in molecular pathology and targeted therapies. Future research should address ET heterogeneity, optimize management of high-risk and special populations, overcome the limitations of targeted therapies, and further elucidate the role of inflammation to achieve individualized precision therapy.
Authors
- Jun‐Min Yan (ORCID: https://orcid.org/0000-0001-8511-3810)
- Li Hou
- Deyou Chen (ORCID: https://orcid.org/0000-0003-3270-8778)
- Haiyan Lang
- Qun Jiang
- Yanqin Wu (ORCID: https://orcid.org/0000-0001-6759-6353)
- Lingyan Chen (ORCID: https://orcid.org/0000-0003-3750-6761)
- Yiming Pan (ORCID: https://orcid.org/0000-0003-4391-0226)
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Wenzhou Medical University (CN)
- Yunnan Provincial Hospital of Traditional Chinese Medicine (CN)
- Guangdong Provincial Hospital of Traditional Chinese Medicine (CN)
- Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (CN)
- Yunnan University of Traditional Chinese Medicine (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1007/s12672-025-02232-9
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China